10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A positive feedback loop reinforces the allergic immune response in human peanut allergy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Peanut-specific CD4 + T cells drive the differentiation of CD209 + DCs, which then act reciprocally on the same CD4 + T cell population to increase Th2 cytokine expression in a positive feedback loop.

          Abstract

          Food allergies are a leading cause of anaphylaxis, and cellular mechanisms involving antigen presentation likely play key roles in their pathogenesis. However, little is known about the response of specific antigen-presenting cell (APC) subsets to food allergens in the setting of food allergies. Here, we show that in peanut-allergic humans, peanut allergen drives the differentiation of CD209 + monocyte-derived dendritic cells (DCs) and CD23 + (FcєRII) myeloid dendritic cells through the action of allergen-specific CD4 + T cells. CD209 + DCs act reciprocally on the same peanut-specific CD4 + T cell population to reinforce Th2 cytokine expression in a positive feedback loop, which may explain the persistence of established food allergy. In support of this novel model, we show clinically that the initiation of oral immunotherapy (OIT) in peanut-allergic patients is associated with a decrease in CD209 + DCs, suggesting that breaking the cycle of positive feedback is associated with therapeutic effect.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Complex heatmaps reveal patterns and correlations in multidimensional genomic data.

            Parallel heatmaps with carefully designed annotation graphics are powerful for efficient visualization of patterns and relationships among high dimensional genomic data. Here we present the ComplexHeatmap package that provides rich functionalities for customizing heatmaps, arranging multiple parallel heatmaps and including user-defined annotation graphics. We demonstrate the power of ComplexHeatmap to easily reveal patterns and correlations among multiple sources of information with four real-world datasets.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Monocyte chemoattractant protein-1 (MCP-1): an overview.

              Chemokines constitute a family of chemoattractant cytokines and are subdivided into four families on the basis of the number and spacing of the conserved cysteine residues in the N-terminus of the protein. Chemokines play a major role in selectively recruiting monocytes, neutrophils, and lymphocytes, as well as in inducing chemotaxis through the activation of G-protein-coupled receptors. Monocyte chemoattractant protein-1 (MCP-1/CCL2) is one of the key chemokines that regulate migration and infiltration of monocytes/macrophages. Both CCL2 and its receptor CCR2 have been demonstrated to be induced and involved in various diseases. Migration of monocytes from the blood stream across the vascular endothelium is required for routine immunological surveillance of tissues, as well as in response to inflammation. This review will discuss these biological processes and the structure and function of CCL2.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: SoftwareRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: InvestigationRole: MethodologyRole: SupervisionRole: Writing - original draftRole: Writing - review & editing
                Role: Resources
                Role: Methodology
                Role: InvestigationRole: Project administrationRole: ResourcesRole: Writing - review & editing
                Role: Formal analysisRole: MethodologyRole: SoftwareRole: Visualization
                Role: ConceptualizationRole: MethodologyRole: SupervisionRole: ValidationRole: Writing - review & editing
                Role: Funding acquisitionRole: ResourcesRole: SupervisionRole: Writing - original draftRole: Writing - review & editing
                Journal
                J Exp Med
                J Exp Med
                jem
                The Journal of Experimental Medicine
                Rockefeller University Press
                0022-1007
                1540-9538
                05 July 2021
                04 May 2021
                04 May 2021
                : 218
                : 7
                : e20201793
                Affiliations
                [1 ]Sean N. Parker Center for Allergy & Asthma Research at Stanford University and Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford, CA
                [2 ]Department of Pediatrics, Program in Immunology, Stanford University, Stanford, CA
                Author notes
                Correspondence to Kari C. Nadeau: knadeau@ 123456stanford.edu

                Disclosures: E.D. Mellins reported grants from Glaxo-Smith-Kline and Novartis outside the submitted work. K.C. Nadeau reported grants from the National Institute of Allergy and Infectious Diseases, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences, and Food Allergy Research and Education; "other" from World Allergy Organization, Cour Pharma, Before Brands, Alladapt, Latitude, IgGenix, Immune Tolerance Network, and the National Institutes of Health clinical research centers outside the submitted work. In addition, K.C. Nadeau had a patent to "inhibition of allergic reaction to peanut allergen using an IL-33 inhibitor" (US patent no. 62/647,389, filed 3/23/2018), a patent to "special oral formula for decreasing food allergy risk and treatment for food allergy (US patent no. 62/119,014, filed 2/20/15, issued 8/15/17) issued, a patent to "basophil activation-based diagnostic allergy test" (US application no. S10-392, filed 10/1/2010), a patent to "granulocyte-based methods for detecting and monitoring immune system disorders" (US application no. 12/686,121, filed 1/12/2010), a patent to "methods and assays for detecting and quantifying pure subpopulations of white blood cells in immune system disorders" (US patent no. 12/610,940, filed 11/2/2009, issued 8/12/2018), a patent to "mixed allergen compositions and methods for using the same" (US patent no. 10/064,936, issued 9/4/2018), and a patent to "microfluidic device and diagnostic methods for allergy testing based on detection of basophil activation" (US patent no. 62/767,444, filed 11/14/2018). No other disclosures were reported.

                [*]

                X. Zhou and W. Yu contributed equally to this work as first authors.

                [**]

                E.D. Mellins and K.C. Nadeau contributed equally to this work as senior authors.

                Author information
                https://orcid.org/0000-0002-3177-3271
                https://orcid.org/0000-0001-5050-5224
                https://orcid.org/0000-0002-0563-362X
                https://orcid.org/0000-0002-5472-8086
                https://orcid.org/0000-0003-3092-0038
                https://orcid.org/0000-0003-3556-8248
                https://orcid.org/0000-0003-2577-139X
                https://orcid.org/0000-0002-2146-2955
                Article
                jem.20201793
                10.1084/jem.20201793
                8103542
                33944900
                41d3f2b5-5526-43af-95d0-4747afb11bad
                © 2021 Zhou et al.

                This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

                History
                : 19 August 2020
                : 18 December 2020
                : 04 March 2021
                Page count
                Pages: 20
                Funding
                Funded by: National Institute of Allergy and Infectious Diseases, DOI http://dx.doi.org/10.13039/100000060;
                Award ID: R01AI140134
                Funded by: National Heart, Lung, and Blood Institute, DOI http://dx.doi.org/10.13039/100000050;
                Award ID: R01HL118612
                Funded by: Sean N. Parker Center for Allergy and Asthma Research at Stanford University;
                Funded by: Stanford Institute for Immunity, Transplantation and Infection;
                Categories
                Article
                Innate Immunity and Inflammation

                Medicine
                Medicine

                Comments

                Comment on this article